We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

3rd Circ. Says Cash Not Key For Pay-For-Delay Suits

Law360, New York (June 26, 2015, 11:24 AM EDT) -- The Third Circuit ruled Friday that pharmaceutical patent settlements do not need to come in the form of a cash payout from a brand to a generic to face antitrust scrutiny...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.